EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats

Ming Zhu, Juan Jia, Huan Tang, Yizhuo Xie, Zhe Lv, Han Bao, Yan Zhang, Dongfanghui Miao, Xin Guo, Kejia Chen, Shanshan Wang, Liangping Yu und 1 weitere

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Ming Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Paclitaxel, Liposomes, Cisplatin, Receptors, Estrogen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Jilin Province, Jilin Province Development and Reform Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian malignancies overexpress estrogen receptors (ERs), offering a therapeutic avenue for targeted drug delivery. Here, we developed a novel ER-targeted PEGylated liposome (ES-SSL-PTX/CDDP) coencapsulating paclitaxel (PTX) and cisplatin (CDDP) to enhance therapeutic efficacy and mitigate systemic toxicity. ES-SSL-PTX/CDDP exhibited a spherical shape with a hydrodynamic diameter of around 150 nm, a negative zeta potential of about -20 mV, and high encapsulation efficiencies of 83.7% for PTX and 41.1% for CDDP. ES-SSL-PTX/CDDP showed a sustained release pattern, with release rates of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelLiposomesCisplatinReceptors, EstrogenOvarian NeoplasmsAntineoplastic AgentsAnimalsFemaleMiceMice, NudeRatsHumansPolyethylene GlycolsRats, Sprague-DawleyMice, Inbred ICRXenograft Model Antitumor AssaysCell Line, TumorDrug Delivery Systems

Stichwörter der Autor:innen

acute and long-term toxicitiesantitumor activityestrogen receptorsovarian cancerpharmacokineticstargeted drug delivery

Substanzen

PaclitaxelLiposomesCisplatinPolyethylene GlycolsReceptors, EstrogenAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
  • Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun 130061, China.

ORCID-Profile: Jin Pei

Förderung

  • Department of Science and Technology of Jilin Province
  • Jilin Province Development and Reform Commission

Zitieren

APA

Zhu, M., Jia, J., Tang, H., Xie, Y., Lv, Z., Bao, H., Zhang, Y., Miao, D., Guo, X., Chen, K., Wang, S., Yu, L., & Pei, J. (2025). Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01457

Vancouver

Zhu M, Jia J, Tang H, Xie Y, Lv Z, Bao H, et al. Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01457

BibTeX
@article{Zhu2025,
  author = {Zhu, Ming and Jia, Juan and Tang, Huan and Xie, Yizhuo and Lv, Zhe and Bao, Han and Zhang, Yan and Miao, Dongfanghui and Guo, Xin and Chen, Kejia and Wang, Shanshan and Yu, Liangping and Pei, Jin},
  title = {Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV-3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01457}
}
Kostenlos starten →